rs375088539
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001363118.2(SLC52A2):c.808C>T(p.Gln270Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000627 in 1,610,796 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001363118.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC52A2 | NM_001363118.2 | c.808C>T | p.Gln270Ter | stop_gained | 3/5 | ENST00000643944.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC52A2 | ENST00000643944.2 | c.808C>T | p.Gln270Ter | stop_gained | 3/5 | NM_001363118.2 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000197 AC: 3AN: 152236Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 247964Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134608
GnomAD4 exome AF: 0.0000672 AC: 98AN: 1458560Hom.: 0 Cov.: 31 AF XY: 0.0000703 AC XY: 51AN XY: 725594
GnomAD4 genome ? AF: 0.0000197 AC: 3AN: 152236Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74376
ClinVar
Submissions by phenotype
Brown-Vialetto-van Laere syndrome 2 Pathogenic:2
Pathogenic, no assertion criteria provided | research | Duke University Health System Sequencing Clinic, Duke University Health System | Mar 25, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Aug 30, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 188051). This premature translational stop signal has been observed in individual(s) with Brown-Vialetto-Van Laere syndrome (BVVLS) (PMID: 27148561). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs375088539, gnomAD 0.004%). This sequence change creates a premature translational stop signal (p.Gln270*) in the SLC52A2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC52A2 are known to be pathogenic (PMID: 24253200). - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jun 21, 2023 | Not observed at a significant frequency in large population cohorts (gnomAD); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 27148561, 34493867, 31836589, 30487145) - |
Brown-Vialetto-van Laere syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Sep 02, 2022 | A heterozygous nonsense variant was identified, NM_001253816.1(SLC52A2):c.808C>T in exon 3 of 5 of the SLC52A2 gene. This nonsense variant is predicted to create a change of a glutamine to a stop at amino acid position 270 of the protein; NP_001240745.1(SLC52A2):p.(Gln270*), resulting in the loss of normal protein function through nonsense-mediated decay (NMD). The variant is present in the gnomAD population database at a global population frequency of 0.0014% (4 heterozygotes, 0 homozygotes) with an African sub-population frequency of 0.0040%. The variant has been previously reported in patients with Brown-Vialetto-Van Laere syndrome (ClinVar, LOVD, Petrovski, S. et al. (2015)). Other variants predicted to cause NMD have also been reported as pathogenic in individuals with this Brown-Vialetto-Van Laere syndrome (ClinVar, Foley, A. R. et al. (2014)). Based on information available at the time of curation, this variant has been classified as PATHOGENIC. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at